Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

Ítems similars

• Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial
  per: Akiyama, Matthew J., et al.
  Publicat: (2019)
• Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
  per: Pericot-Valverde, Irene, et al.
  Publicat: (2020)
• Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
  per: Pericot-Valverde, Irene, et al.
  Publicat: (2020)
• Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy
  per: Akiyama, Matthew J, et al.
  Publicat: (2020)
• Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents
  per: Norton, Brianna L, et al.
  Publicat: (2020)